Pleural Mesothelioma
Showing 1 - 25 of 1,061
Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in
Recruiting
- Malignant Pleural Mesothelioma, Advanced
- Oncolytic Adenovirus H101
- Programmed death receptor-1 inhibitor
-
Tianjin, Tianjin, ChinaTianjin Medical Unversity Second Hospital
Sep 2, 2023
Pleural Mesothelioma Trial in Guangzhou (Cadonilimab+Bevacizumab+Pemetrexed+Carboplatin)
Not yet recruiting
- Pleural Mesothelioma
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jul 3, 2023
Malignant Pleural Mesothelioma Trial (Proton beam therapy)
Not yet recruiting
- Malignant Pleural Mesothelioma
- Proton beam therapy
- (no location specified)
Dec 14, 2022
Pleural Mesothelioma Trial in Italy (Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab)
Not yet recruiting
- Pleural Mesothelioma
- Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab
-
Rozzano, MI, Italy
- +5 more
Nov 30, 2023
Malignant Pleural Mesothelioma, Mesothelioma Trial in Tampa (Cisplatin, Methotrexate, Gemcitabine)
Active, not recruiting
- Malignant Pleural Mesothelioma
- Mesothelioma
- Cisplatin
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 5, 2023
Malignant Pleural Mesothelioma Trial in Cairo (Gemcitabine, supportive care)
Not yet recruiting
- Malignant Pleural Mesothelioma
- Gemcitabine
- supportive care
-
Cairo, EgyptAin Shams University Hospital
Dec 20, 2022
TTFields in General Routine Clinical Care in Pleural
Not yet recruiting
- Pleural Mesothelioma
- TTFields
- (no location specified)
Sep 9, 2022
Mesotheliomas Pleural Trial in Amsterdam (Pembrolizumab, Lenvatinib)
Recruiting
- Mesotheliomas Pleural
-
Amsterdam, Noord-Holland, NetherlandsAntoni van Leeuwenhoekziekenhuis (NKI-AVL)
Jan 13, 2023
Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))
Completed
- Pleural Mesothelioma
- Cyclophosphamide
- +3 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jan 8, 2023
Malignant Pleural Mesothelioma Trial in Edegem, Ghent, Sint-Niklaas (Dendritic cell vaccination, Atezolizumab,
Not yet recruiting
- Malignant Pleural Mesothelioma
- Dendritic cell vaccination
- +2 more
-
Edegem, Antwerp, Belgium
- +2 more
Feb 28, 2023
Malignant Pleural Mesothelioma Trial in United States (E-Nose testing, Research blood)
Recruiting
- Malignant Pleural Mesothelioma
- E-Nose testing
- Research blood
-
Basking Ridge, New Jersey
- +6 more
Sep 8, 2023
Malignant Pleural Mesothelioma, Chemo Effect Trial in Cairo (hyperthermic intrathoracic chemo)
Recruiting
- Malignant Pleural Mesothelioma
- Chemotherapy Effect
- hyperthermic intrathoracic chemotherapy
-
Cairo, EgyptAin Shams University hospitals
Aug 18, 2022
Clinical, Radiological and Patient Reported Outcomes After
Recruiting
- Pleural Diseases
- +9 more
- Pleural interventions
-
Oxford, Oxfordshire, United KingdomOxford University Hospitals NHS Foundation Trust
Jun 8, 2023
Malignant Pleural Mesothelioma Trial in Philadelphia (OT-101)
Not yet recruiting
- Malignant Pleural Mesothelioma
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jun 16, 2022
Non Small Cell Lung Cancer (NSCLC), Malignant Pleural Mesothelioma (MPM) Trial in Marseille (Vinorelbine)
Completed
- Non Small Cell Lung Cancer (NSCLC)
- Malignant Pleural Mesothelioma (MPM)
-
Marseille, FranceAssistance Publique des Hôpitaux de Marseille (CEPCM)
Nov 15, 2022
Mesothelioma Trial in Boston (MPT Test, CLDN15/VIM Test)
Recruiting
- Mesothelioma
- MPT Test
- CLDN15/VIM Test
-
Boston, MassachusettsBrigham and Women's Hospital
Mar 21, 2022
Mesothelioma Trial in Durham, Houston (Durvalumab / tremelimumab, Platinum cisplatin or carboplatin and pemetrexed chemo plus
Not yet recruiting
- Mesothelioma
- Durvalumab / tremelimumab
- Platinum cisplatin or carboplatin and pemetrexed chemotherapy plus durvalumab/tremelimumab
-
Durham, North Carolina
- +1 more
Jul 5, 2023
Biological Characteristics of Mesothelioma Patients
Completed
- Malignant Mesothelioma
-
Rozzano, Milano, Italy
- +1 more
Sep 8, 2022
Malignant Pleural Effusion, Malignant Pleural Mesothelioma, Mesothelioma Trial in Leicester (RSO-021)
Recruiting
- Malignant Pleural Effusion
- +3 more
-
Leicester, United Kingdom
- +5 more
Oct 28, 2022
Malignant Pleural Mesothelioma Trial in Houston (Dasatinib)
Active, not recruiting
- Malignant Pleural Mesothelioma
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 25, 2022
Malignant Pleural Mesothelioma Trial in New York (Safety, Expansion Cohort)
Recruiting
- Malignant Pleural Mesothelioma
- Safety
- Expansion Cohort
-
New York, New YorkIcahn School of Medicine Mount Sinai
Mar 31, 2022
Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma
Recruiting
- Mesothelioma, Malignant
-
Shinjuku-ku, Tokyo, JapanLocal Institution
Apr 5, 2022
Mesothelioma, Pleural Mesothelioma, Wilms Tumor Trial in United States (Galinpepimut-S, Nivolumab, Sargramostim)
Active, not recruiting
- Mesothelioma
- +2 more
- Galinpepimut-S
- +2 more
-
Basking Ridge, New Jersey
- +5 more
Nov 23, 2022
Pleural Mesothelioma Trial in Rochester (Immunotherapy, Quality-of-Life Assessment, Stereotactic Body Radiation Therapy)
Recruiting
- Pleural Mesothelioma
- Immunotherapy
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Pleural Mesothelioma Malignant Advanced Trial in Spain, Switzerland, United Kingdom (Pembrolizumab, Gemcitabine, Vinorelbine)
Completed
- Pleural Mesothelioma Malignant Advanced
- Pembrolizumab
- +2 more
-
Barcelona, Spain
- +14 more
Aug 23, 2022